Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells

Yan Wang, Wei Cheng Liang, Wen Liang Pan, Wai Kit Law, Jian Shu Hu, Denis Tsz Ming Ip, Mary Miu Yee Waye, Tzi Bun Ng, David Chi Cheong Wan

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences